1250807

Covis Pharma GmBH — FEI 3008152278

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
September 19, 2024
Fiscal Year
2024
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Waltham, MA (United States)

Additional Details

Postmarket Adverse Drug Experience (PADE)